arrow
P

Paolo Scollo

Università Kore di Enna
H指数:28
被引数:2,969

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Surgical Timing in Advanced Ovarian Cancer During the TRUST Trial Era: A Systematic Review, Meta-Analysis and Study-Level Meta-regression of Randomized Controlled Trials

TRUST试验时期晚期卵巢癌的手术时机:一项系统评价、随机对照试验的Meta分析及研究水平的Meta回归

2025-12-180
OAAI
The Impact of Non-Radical Hysterectomy on Urinary Functions: Evaluation of Symptoms—A Systematic Review and Meta-Analysis

非根治性子宫切除术对泌尿功能的影响:症状评估——系统评价与荟萃分析

2025-10-170
OAAI
Correction: Restaino et al. Management of Patients with Vulvar Cancers: A Systematic Comparison of International Guidelines (NCCN–ASCO–ESGO–BGCS–IGCS–FIGO–French Guidelines–RCOG). Cancers 2025, 17, 186

更正:Restaino等人,妇科癌症患者的管理:国际指南的系统比较(NCCN–ASCO–ESGO–BGCS–IGCS–FIGO–法国指南–RCOG)。Cancers 2025, 17, 186

2025-09-270
OAAI
Trabectedin maintenance therapy after liposomal doxorubicin plus trabectedin combination in patients with relapsed ovarian cancer: the randomized, phase II TRAMANT study

复发性卵巢癌患者脂质体多柔比星联合小梁培定后的小梁培定维持治疗: 随机,II期TRAMANT研究

2025-05-240
OAAI
Exploit the γ-Glutamyl hydroxymethyl rhodamine green fluorescence in surgical resection: A systematic literature review on clinical indications, fields of application and outcomes

利用γ-谷氨酰羟甲基罗丹明绿荧光进行手术切除:关于临床适应症、应用领域和结局的系统文献综述

2025-03-280
PRE
Up-regulated microRNAs in blastocoel fluid of human implanted embryos could control circuits of pluripotency and be related to embryo competence
2025-03-010
OAAI
Identification of the novel BRCA1 c.2463_2464delTA mutation in two high grade serous ovarian cancer sisters and potential dosage effects implications: a case report (vol 52, 103, 2025)

鉴定一种新型BRCA1 c.2463_2464delTA突变在两名高级别浆液性卵巢癌姐妹中的发现及其潜在的剂量效应影响:病例报告(卷52,103,2025)

2025-02-070
PRE
Unraveling the complexity of HRD assessment in ovarian cancer by combining genomic and functional approaches: translational analyses of MITO16-MaNGO-OV-2 trial
2025-01-011
OAAI